These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15000429)

  • 1. Development of 400 microm pellets by extrusion-spheronization: application with Gelucire 50/02 to produce a "sprinkle" form.
    Flament MP; Dupont G; Leterme P; Farah N; Gayot A
    Drug Dev Ind Pharm; 2004 Jan; 30(1):43-51. PubMed ID: 15000429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrusion-spheronization manufacture of Gelucire matrix beads.
    Montoussé C; Pruvost M; Rodriguez F; Brossard C
    Drug Dev Ind Pharm; 1999 Jan; 25(1):75-80. PubMed ID: 10028421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. II. Sphere characteristics.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):413-22. PubMed ID: 9876603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feasibility of 400 microm spheroids by extrusion-spheronization].
    Flament M; Leterme P; Gayot A
    Ann Pharm Fr; 2000 May; 58(3):195-200. PubMed ID: 10844281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of plate design on the properties of pellets produced by extrusion and spheronization.
    Michie H; Podczeck F; Newton JM
    Int J Pharm; 2012 Sep; 434(1-2):175-82. PubMed ID: 22659150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
    Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
    Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of process variables on physical properties of the pellets using extruder and spheronizer.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Jan; 25(1):45-61. PubMed ID: 10028418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a study method for producing 400 microm spheroids.
    Dupont G; Flament MP; Leterme P; Farah N; Gayot A
    Int J Pharm; 2002 Oct; 247(1-2):159-65. PubMed ID: 12429494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. I. Extrusion behavior of formulations.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):401-11. PubMed ID: 9876602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.
    Krueger C; Thommes M
    Pharm Dev Technol; 2013 Feb; 18(1):225-35. PubMed ID: 22780876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the drying technique on theophylline pellets prepared by extrusion-spheronization.
    Pérez J; Rabisková M
    Int J Pharm; 2002 Aug; 242(1-2):349-51. PubMed ID: 12176277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spheronization of small extrudates containing kappa-carrageenan.
    Yoo A; Kleinebudde P
    J Pharm Sci; 2009 Oct; 98(10):3776-87. PubMed ID: 19130471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the mechanism of dissolution rate enhancement of poorly water-soluble drugs from spray chilled gelucire 50/13 microspheres.
    Qi S; Marchaud D; Craig DQ
    J Pharm Sci; 2010 Jan; 99(1):262-74. PubMed ID: 19653284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S; Newton JM; Bloor JR; Hayes G
    Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of homogenization method on the properties of carbamazepine microparticles prepared by spray congealing.
    Martins RM; Siqueira S; Machado MO; Freitas LA
    J Microencapsul; 2013; 30(7):692-700. PubMed ID: 23534493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticle size control and glimepiride microencapsulation using spray congealing technology.
    Ilić I; Dreu R; Burjak M; Homar M; Kerc J; Srcic S
    Int J Pharm; 2009 Nov; 381(2):176-83. PubMed ID: 19446625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.